🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 12 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/10/2017 50,75 51,77 50,42 51,17 +0,20% 2,66% 1.156.200
10/10/2017 51,21 51,60 49,77 51,07 -0,37% 3,57% 1.765.700
09/10/2017 51,03 52,03 50,30 51,26 +1,08% 3,39% 2.120.000
06/10/2017 50,50 51,97 49,74 50,71 +0,90% 4,42% 1.852.600
05/10/2017 49,75 50,41 49,35 50,26 +0,96% 2,13% 950.000
04/10/2017 48,83 50,48 48,36 49,78 +1,22% 4,34% 1.356.200
03/10/2017 50,00 50,19 48,19 49,18 -0,75% 4,00% 1.898.400
02/10/2017 47,00 49,58 46,55 49,55 +9,24% 6,45% 4.553.000
29/09/2017 47,15 47,72 42,97 45,36 -3,80% 10,07% 9.172.900
28/09/2017 46,00 47,78 45,78 47,15 +1,18% 4,35% 1.983.900
27/09/2017 44,48 46,84 44,37 46,60 +5,10% 5,55% 1.783.300
26/09/2017 44,21 44,88 43,43 44,34 +1,00% 3,28% 1.381.200
25/09/2017 45,37 45,97 43,64 43,90 -2,81% 5,14% 2.302.000
22/09/2017 46,97 46,97 45,03 45,17 -4,10% 4,13% 1.821.700
21/09/2017 46,50 47,28 45,95 47,10 +0,79% 2,86% 1.222.700
20/09/2017 45,75 46,86 45,26 46,73 +2,10% 3,50% 1.588.000
19/09/2017 47,17 47,48 45,71 45,77 -2,26% 3,75% 1.638.600
18/09/2017 46,53 47,41 46,06 46,83 +0,69% 2,90% 1.798.000
15/09/2017 46,20 47,07 45,61 46,51 +0,69% 3,16% 3.466.200
14/09/2017 44,66 46,30 44,15 46,19 +3,13% 4,81% 2.221.500
13/09/2017 44,12 45,43 43,77 44,79 +1,56% 3,76% 1.454.900
12/09/2017 44,49 44,93 43,57 44,10 -1,08% 3,06% 1.558.600
11/09/2017 43,68 45,07 42,35 44,58 +3,65% 6,23% 2.649.200
08/09/2017 45,25 45,48 42,73 43,01 -5,22% 6,08% 2.882.600
07/09/2017 47,58 47,59 44,99 45,38 -2,89% 5,46% 3.787.700
06/09/2017 46,34 47,96 44,77 46,73 +13,75% 6,88% 12.382.500
05/09/2017 40,93 41,50 39,79 41,08 -0,36% 4,18% 1.536.700
01/09/2017 40,35 41,25 39,25 41,23 +2,33% 4,96% 1.953.900
31/08/2017 39,58 40,66 38,64 40,29 +2,60% 5,10% 2.620.300
30/08/2017 38,41 39,50 38,24 39,27 +2,67% 3,28% 1.751.900